This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism
Signal Transduction and Targeted Therapy Open Access 22 March 2023
-
Dynamic rewiring of biological activity across genotype and lineage revealed by context-dependent functional interactions
Genome Biology Open Access 29 June 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Li, Y., He, Y., Peng, J. et al. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Nat. Can. https://www.nature.com/articles/s43018-020-00134-z (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
O’Leary, K. Tracing the origins of KRAS oncogene addiction. Nat Rev Cancer 21, 69 (2021). https://doi.org/10.1038/s41568-020-00325-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-020-00325-x
This article is cited by
-
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism
Signal Transduction and Targeted Therapy (2023)
-
Dynamic rewiring of biological activity across genotype and lineage revealed by context-dependent functional interactions
Genome Biology (2022)